Today, artificial intelligence technologies (AI) add significant complexities to organizational learning, performance, and change, and these technologies are proliferating across all industries at rapidly increasing rates (West, 2018). However, most organizations do not understand how to make sense of AI (Brynjolfsson & McAfee, 2017), and the…

The field of research impact assessment (RIA) has seen remarkable growth over the past three decades. Increasing numbers of RIA frameworks have been developed and applied by research funders and new technologies can capture some research impacts automatically. However, RIAs are too different to draw comparable conclusions about what type of…

Public research organizations respond to external pressures from national research evaluation systems, performance-based funding systems and university rankings by translating them into internal goals, rules and regulations and by developing organizational identities, profiles and missions. Organizational responses have primarily been studied at…

Although several entrepreneurship education programs (EEPs) have been created for faculty, research examining women faculty experiences participating in EEPs is minimal and particularly negligible in the context of their academic research. To address this gap, we examine women faculty's perceptions and experiences toward EEPs in the context of…

The field of biomedical research has undergone several changes in recent years. These include increased funding, the rapid development in scientific knowledge which speeds up the obsolescence of equipment, facilities and knowledge and the growing complexity of scientific problems. Research administrators can take steps to address these changes…

Bridge-funding by tertiary-educational institutions allows researchers to continue their research in times of funding loss. With the ever-declining funding rates for major medical research institutions in North America, and the global economic downturn, it is crucial to critically assess institutional policies surrounding the allocation of…

Public funding for biomedical research is often justified as a means to encourage development of more (and better) treatments for disease. However, few studies have investigated the relationship between these expenditures and downstream pharmaceutical innovation. In particular, although recent analyses have shown a clear contribution of federally…

Relying upon grant-supported salaries, many medical schools have greatly expanded their faculties; but if new funding devices are not discovered, retrenchment will occur. Physicians, who are trained to look at the big picture, must continue to be an essential element in the biomedical research team. (MLW)

Paper delivered to the the Council of Academic Societies, Chicago, Illinois, February 1970. (IR)

Discusses unpaid postdoctoral researchers, especially those in biology and medicine, addressing reasons why they work without pay, how they receive funding, efforts to help them, their impacts on the field, and personal concerns. (DC)

Introduces Minority Opportunities in Research programs of the National Institute of General Medical Sciences: Minority Access to Research Careers Program, Minority Biomedical Research Support Program, National Minority Predoctoral Fellowship Program, and Research Supplements for Underrepresented Minorities Program. These programs provide financial…

The scientific community's expectations for biomedical research exceed funding capacity. Despite national social and economic problems, funding for biomedical research is already high. Additional funds will not solve the problem entirely. The biomedical community must set priorities and allocate money accordingly. New policies for allocating funds…

Alternative sources and innovative programs are suggested to improve or maintain adequate research support, including hard funding in the institution's operating budget, private gifts, Biomedical Research Support Grants from the National Institutes of Health, and applied research supported by industrial clients. (MSE)